Wegovy and Light Sensitivity: What the Evidence Actually Says

You have started Wegovy and the world suddenly seems very bright — here is what is probably happening

Picture the first few weeks on Wegovy: appetite has dropped sharply, you may have had some nausea or loose stools, and you are drinking less than usual because nothing sounds appetising. Dehydration is one of the most common and underappreciated contributors to light discomfort. The eyes are sensitive to electrolyte shifts, and even mild dehydration can make fluorescent lighting or a bright phone screen feel genuinely unpleasant in a way it did not before.

Fatigue compounds this. The gut-hormone activity that Wegovy produces (slowing gastric emptying, suppressing appetite) can leave some people feeling wrung out in the adjustment period, particularly after a dose step up. Tired eyes are more reactive eyes. None of this means the medicine is damaging your vision; it means your body is adapting, and the adaptation can briefly make sensory experiences feel turned up.

The practical habit worth building: for one week after any dose increase, keep a rough note on your phone of how much you are drinking each day. Most adults need at least 1.5 to 2 litres. If your fluid intake has quietly collapsed alongside your appetite, that is worth correcting before concluding the medicine is to blame for the discomfort. It takes under a minute and often reveals a simple explanation. The Wegovy treatment overview covers what else to expect during the adjustment window.

What the Wegovy prescribing information says about the eyes, and where caution is genuinely warranted

The UK Summary of Product Characteristics for semaglutide does not list photophobia or light sensitivity among its recognised adverse reactions. The NHS patient information on semaglutide describes the side-effect profile as predominantly gastrointestinal: nausea, vomiting, diarrhoea, constipation, burping, reflux. These typically peak shortly after starting or stepping up a dose, then settle over days to a few weeks for most people.

There is, however, one eye-related issue that does appear in the clinical literature: diabetic retinopathy. In people with type 2 diabetes, rapid improvements in blood sugar control can temporarily affect the retina, and this has been observed with semaglutide in that population. Wegovy is licensed for weight management rather than diabetes, but prescribers are aware of this signal and it is one reason why sudden changes to vision, blurring, or flashes of light must be treated as urgent rather than watched and waited on. If you use semaglutide for weight management and also have diabetes, mention any visual changes to your prescriber without delay.

People who notice changes to how their skin responds to sunlight during treatment may find the detail on sun sensitivity on Wegovy useful reading alongside this page.

When to stop wondering and get help

Most light discomfort that appears in the first weeks of Wegovy treatment and tracks with tiredness or dehydration is benign and self-resolving. The situations that need prompt medical assessment are different in character: sudden loss or blurring of vision, new floaters or flashes, eye pain, persistent headache behind the eyes, or a change in colour perception. These are not expected features of GLP-1 treatment and should be seen by a GP or optician the same day, not left until the next routine review.

Skin-level sensitivity to light is a different question again. Some semaglutide users report that their skin feels different (more reactive, drier, or more prone to flushing) and there is a separate discussion on skin sensitivity during Wegovy treatment for that. Similarly, if what you have noticed is less about light and more about changes to how things smell, our page on altered smell on semaglutide addresses that specific question.

The MHRA's Yellow Card scheme exists precisely for this kind of reporting: if you believe you are experiencing a side effect not described in your Patient Information Leaflet, you can submit it at yellowcard.mhra.gov.uk. It is a genuine public-health tool, not just a formality. If cost is on your mind alongside all of this, a quick look at Wegovy pricing in the UK sets out what private treatment typically involves. And if you have not yet spoken to a prescriber about whether Wegovy is right for you, the best next step is a free consultation with our clinical team.